Advertisement

Topics

Arsenal Capital Buys Cyalume for $45 million

08:01 EDT 15 Aug 2017 | CHEManager

New York-based private equity group Arsenal Capital Partners has signed a definitive agreement to acquire Cyalume Technologies Holdings for $45 million in cash.

Original Article: Arsenal Capital Buys Cyalume for $45 million

NEXT ARTICLE

More From BioPortfolio on "Arsenal Capital Buys Cyalume for $45 million"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...